Effects of lectin-like oxidized LDL receptor-1 (LOX-1) inhibition in human aortic endothelial cells (HAECs).
Chih-Sheng Chu
Yu-Chen Wang
Long-Sheng Lu
Brian Walton
H. Ramazan Yilmaz
Roger Y. Huang
Tatsuya Sawamura
Richard A. F. Dixon
Wen-Ter Lai
Chu-Huang Chen
Jonathan Lu
10.1371/journal.pone.0070533.g004
https://plos.figshare.com/articles/figure/_Effects_of_lectin_like_oxidized_LDL_receptor_1_LOX_1_inhibition_in_human_aortic_endothelial_cells_HAECs_/767713
<p>(A) HAECs were pretreated with LOX-1 neutralizing antibody TS92 before the introduction of L1 or L5 into cell culture. (B) HAECs were pretreated with TS92 before the introduction of recombinant human CRP (5 or 50 µg/mL) into cell culture. For all experiments, n = 3, and bars shown in graphs represent standard deviation. *<i>P</i><0.05 vs. untreated control.</p>
2013-08-08 02:41:45
Biochemistry
proteins
lipoproteins
Lipoprotein receptors
Molecular cell biology
chromatography
cardiovascular
atherosclerosis
Diagnostic medicine
lectin-like
oxidized
ldl
receptor-1
inhibition
aortic
endothelial
cells